Holen Sie sich die Stockscreener-App
3.60
1.37%
-0.05
Handel nachbörslich:
3.60
Clene Inc Aktie (CLNN) Neueste Nachrichten
Clene Posts 70% Revenue Drop in Q2 - The Motley Fool
Clene Inc. (CLNN) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Clene Reports Second Quarter 2025 Financial Results and Recent Operating Highlights - The Globe and Mail
Clene Amends Notes and Secures New Financing - TipRanks
Clene Inc. Announces Q2 2025 Financial Results and Plans for FDA Meetings on CNM-Au8® Development in ALS and MS - Quiver Quantitative
Clene to Submit ALS New Drug Application in Q4 2025 - AInvest
Clene's ALS Treatment Shows Survival Benefits, Plans FDA Filing as Cash Position Strengthens - Stock Titan
Clene Inc. SEC 10-Q Report - TradingView
| MarketBeat - MarketBeat
Clene (NASDAQ: CLNN) to Present Corporate Update at Emerging Growth Conference on Aug. 20 - The Globe and Mail
Clene to Present at the Emerging Growth Conference | CLNN Stock News - GuruFocus
Neurodegenerative Disease Treatment Developer Clene Sets Key Investor Update on ALS Progress - Stock Titan
Clene Inc. Equity Warrant Crosses 200 Day MA — Signal or NoiseJuly 2025 Outlook & Free Real-Time Volume Trigger Notifications - 선데이타임즈
Nanomedicines Market from 2025 to 2032: Significant Growth - openPR.com
Why Clene Inc. stock attracts strong analyst attention2025 Earnings Impact & High Return Stock Watch Alerts - newsyoung.net
Clene (NASDAQ: CLNN) Partners with APST Research to Advance ALS Drug Approval Process - The Globe and Mail
Vanguard Extended Market ETF (VXF) Expected to Reach $233 - AInvest
Clene Inc. Could See a Relief Rally From SupportROI Boosting Trade Opportunity Calendar Published - beatles.ru
CANACCORD GENUITY GROUP INC. REPORT ON VOTING RESULTS FROM ANNUAL GENERAL MEETING - The Globe and Mail
Piedmont Lithium Announces Updated Timetable for Merger with Sayona Mining - The Globe and Mail
Government Upholds Broken Telecom Regime, Jeopardizing Canada's Prosperity - The Globe and Mail
Clene (NASDAQ: CLNN) To Present At Canaccord 45th Annual Growth Conference - Barchart.com
Clene (NASDAQ: CLNN) to Present at Canaccord 45th Annual Growth Conference - The Globe and Mail
Watch for Trend Continuation in Clene Inc. Equity Warrant Next WeekSmart Allocation Growth Setup Plan - beatles.ru
Clene Inc. to Present at Canaccord 45th Annual Growth Conference on August 12, 2025 - Quiver Quantitative
Clene to Present at the Canaccord 45th Annual Growth Conference - The Manila Times
ALS and MS Treatment Developer Clene to Reveal Latest Progress at Major Growth Conference - Stock Titan
Shift4 Announces Second Quarter 2025 Results - The Globe and Mail
Sentiment Turns Positive on Clene Inc. — Reversal AheadIntraday Trend Analysis for Fast Gains Released - metal.it
Why Clene Inc. Equity Warrant stock attracts strong analyst attentionConservative Entry for High Return Setup Backed - beatles.ru
What is the risk reward ratio of investing in Clene Inc. stockTriple-digit wealth increases - Jammu Links News
What analysts say about Clene Inc. Equity Warrant stockUnlock expert trading strategies for growth - Jammu Links News
What is Clene Inc. company’s growth strategyMassive profits - Jammu Links News
What is the dividend policy of Clene Inc. stockHigh-velocity capital appreciation - Jammu Links News
Is Clene Inc. a growth stock or a value stockUnprecedented profits - Jammu Links News
Is it the right time to buy Clene Inc. stockOutstanding trading profits - Jammu Links News
What markets is Clene Inc. expanding into Is MURA stock a good long term investment optionCapitalize on market momentum for maximum gains - Jammu Links News
What are analysts’ price targets for Clene Inc. Equity Warrant in the next 12 monthsBuild a portfolio that grows with the market - Jammu Links News
Why is Clene Inc. stock attracting strong analyst attentionDouble-digit growth - Jammu Links News
Is it the right time to buy Clene Inc. Equity Warrant stockRapid growth opportunities - Jammu Links News
How volatile is Clene Inc. Equity Warrant stock compared to the marketAccelerated wealth building - Jammu Links News
What drives Clene Inc. Equity Warrant stock priceCapitalize on high-yield stocks early - Jammu Links News
How does Clene Inc. Equity Warrant compare to its industry peersExceptional stock performance - Jammu Links News
What institutional investors are buying Clene Inc. stockFree Capital Allocation Plans - Jammu Links News
Clene (NASDAQ: CLNN) Reports CNM-Au8 Significantly Improves Survival in ALS Patients - The Globe and Mail
What are Clene Inc. Equity Warrant company’s key revenue driversOutperformance with explosive growth - Jammu Links News
Published on: 2025-08-03 11:24:38 - Jammu Links News
What are the technical indicators suggesting about Clene Inc.Explosive portfolio gains - Jammu Links News
Does Clene Inc. Equity Warrant stock perform well during market downturnsOutstanding investment returns - Jammu Links News
How many analysts rate Clene Inc. as a “Buy”Get real-time alerts on top-performing stocks - Jammu Links News
What drives Clene Inc. stock priceUnbelievable profit margins - Jammu Links News
Is Clene Inc. Equity Warrant a growth stock or a value stockDiscover stocks with strong growth potential - Jammu Links News
What is Clene Inc. Equity Warrant company’s growth strategyCapitalize on fast-growing stocks today - Jammu Links News
What catalysts could drive Clene Inc. Equity Warrant stock higher in 2025Invest smarter with actionable market insights - Jammu Links News
What are the latest earnings results for Clene Inc.Exceptional risk-adjusted gains - Jammu Links News
Published on: 2025-08-03 02:32:15 - Jammu Links News
0.43%
1.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):